University Hospital—University Hospital Performs First Transplant with Machine Preserved Liver in the State of New Jersey

In this press release, University Hospital announces the successful transplantation of a donated liver preserved by portable hypothermic machine perfusion, a first in the state of New Jersey. The liver was preserved using the LifePort^® Liver Transporter during the PILOT^™ clinical trial. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a prospective randomized multi-center oxygenated hypothermic machine perfusion study using the LifePort Liver Transporter (LLT) system with Vasosol as compared to static cold storage in orthotopic liver transplantation.

“There is a very short window of time for a surgeon to safely recover a donated organ, determine its quality and viability, and then successfully transplant into a patient; every second counts. Having new technology to potentially expand that crucial timeframe can be the determining factor in conducting a successful transplantation operation.”

One of the principal teaching hospitals for Rutgers Biomedical and Health Sciences, University Hospital is the center of referral for many of the state’s most advanced medical services and specialty care programs. University Hospital houses New Jersey’s first Liver Transplant Program.

Tagged In:

The Latest

Check out the most recent posts

Novel Oxygenation Technique for Hypothermic Machine Perfusion of Liver Grafts: Validation in Porcine Donation after Cardiac Death (DCD) Liver Model

Clinical Evidence

In a pre-clinical study using a porcine DCD model, Panayotova et al. sought to validate the novel technique of oxygen “pre-charge” for hypothermic machine perfusion (HMP) using the LifePort Liver Transporter. The study evaluated the effects of this preservation method...

David’s Transplant Journey

News

In this powerful video, we meet David, a liver recipient who shares his journey of needing a liver transplant. David speaks about the emotional and physical toll of waiting for a liver to become available, not knowing when or if he would receive that call. David takes...

Changing liver utilization and discard rates in clinical transplantation in the ex-vivo machine preservation era

Clinical Evidence

A recent review article by Azizieh et al. focused on the implementation of ex-vivo machine preservation and how it might change the perception of organ acceptability. By focusing on machine perfusion, they explored the effects of the different modalities on outcomes...

Therapeutic Hypothermia or Hypothermic Machine Perfusion (HMP) which is best for Kidney Transplant Outcomes?

Clinical Evidence

In 2023, Malinoski et al. published the results from a pragmatic, adaptive, prospective, randomized trial that was conducted between August 10, 2017, and May 21, 2020 involving six OPOs in the US. They sought to determine whether targeted mild hypothermia is as...